Fast Five Quiz: Treatment of Hereditary (Familial) Transthyretin-Related Amyloidosis (hATTR)

Hereditary (familial) transthyretin-related amyloidosis (hATTR) is a rare, severely debilitating, and often fatal disorder caused by a mutation in the gene encoding transthyretin (TTR). It results in abnormal amyloid protein buildup in multiple organ systems, leading to progressive peripheral neuropathy, cardiomyopathy, nephropathy, and gastrointestinal dysfunction. Due to the multiorgan system involvement of the disease, an interdisciplinary approach to treatment is crucial to manage all comorbidities. Available treatment modalities include surgical and pharmacotherapeutic options.

How much do you know about the treatment of hATTR? Test your knowledge with this quick quiz.

Medscape © 2021 WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Jefferson R. Roberts, Victoria M.F. Mank. Fast Five Quiz: Treatment of Hereditary (Familial) Transthyretin-Related Amyloidosis (hATTR) - Medscape - Feb 05, 2021.